Acylheparanase induction was associated with reduced CXCL10 levels, suggesting that this chemokine plays a tumor suppressive role in myeloma. Indeed, recombinant CXCL10 attenuated the proliferation of CAG, U266, and RPMI-8266 myeloma cells. Here, CXCL10 is linked to plasma cell myeloma.